Abstract 6777: Characterization of the dual MCT1 and MCT4 inhibitor MCT-IN-1 in MOC1 cell line demonstrates increased apoptosis and compensatory upregulation of glutathione conjugation gene sets

Abstract Background: Head and neck squamous cell carcinoma, like many solid tumors, upregulates glycolysis regardless of O2 availability via the Warburg effect, which results in accumulation of intracellular lactate. To avoid apoptosis from the resultant decreased pH, these cells export lactate via monocarboxylate transporters (MCT), primarily MCT1 and MCT4, with overexpression of MCT1 and MCT4 having been linked to poor prognosis. Methods: Mouse Oral Cancer (MOC1) cells were treated with MCT-IN-1, a dual MCT1 and MCT4 inhibitor. Flow cytometry was utilized to characterize apoptosis and S-phase of the cell cycle. Bulk RNAseq data were obtained from both MCT-IN-1-treated and untreated MOC1 cells and analyzed with unbiased gene set enrichment analysis (GSEA). Leading edges of enrichment were analyzed by using the STRING database of protein-protein interactions. Results: Treatment of MOC1 cells with MCT-IN-1 resulted in decreased tumor cell count (p<0.01), increased apoptosis (p<0.01), and reduced S-phase of the cell cycle (p<0.01) compared to untreated cells. Unbiased GSEA of bulk RNAseq data, contrasting MCT-IN-1 treated versus untreated cells, revealed upregulation of endoplasmic reticulum (ER) stress (NES 1.79, FDR=0.012), suggesting possible mechanism of cell death. In addition, the glutathione conjugation gene set was found to be upregulated (NES 1.75, FDR=0.016), suggesting a possible compensatory response mechanism. Further, GSEA revealed significant enrichment of the oxidative stress and redox pathway (NES 1.74, FDR=0.016), including glutathione transferase and oxidoreductase activities. STRING analysis of upregulations in gene expression revealed a dense protein-protein interaction network, suggesting coordinated roles in detoxification (FDR = 1.00e-16) and cellular stress response mechanisms (FDR = 2.61e-41) in MOC1 cells treated with MCT-IN-1. Conclusions: We report the first characterization of the dual MCT1 and MCT4 inhibitor MCT-IN-1. Treatment of MOC1 cells in vitro with MCT-IN-1 induces tumor cell apoptosis possibly via upregulation of ER stress and further demonstrates upregulation of glutathione conjugation gene sets, suggesting a possible compensatory mechanism. Validation with in vivo studies and further evaluation of the exact mechanism of these findings are required. Citation Format: Eric V. Mastrolonardo, Víctor Díaz Barros, Zhao Lin, Hani Samarah, Julian Jackson, Adam J. Luginbuhl, Alban Linnenbach, Ubaldo Martinez-Outschoorn, Joseph M. Curry. Characterization of the dual MCT1 and MCT4 inhibitor MCT-IN-1 in MOC1 cell line demonstrates increased apoptosis and compensatory upregulation of glutathione conjugation gene sets [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6777.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-6777
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 6777: Characterization of the dual MCT1 and MCT4 inhibitor MCT-IN-1 in MOC1 cell line demonstrates increased apoptosis and compensatory upregulation of glutathione conjugation gene sets

Alban J. Linnenbach, Eric V. Mastrolonardo, Joseph Curry, Adam Luginbuhl et al.
1 links
Cancer Research
Cancer-related molecular mechanisms research
article

Abstract 6777: Characterization of the dual MCT1 and MCT4 inhibitor MCT-IN-1 in MOC1 cell line demonstrates increased apoptosis and compensatory upregulation of glutathione conjugation gene sets

Alban J. Linnenbach, Eric V. Mastrolonardo, Joseph Curry, Adam Luginbuhl, Hani Samarah, Ubaldo Martinez‐Outschoorn, Lin Zhao, Julian Jackson, Víctor Díaz Barros
article en

Abstract

Abstract Background: Head and neck squamous cell carcinoma, like many solid tumors, upregulates glycolysis regardless of O2 availability via the Warburg effect, which results in accumulation of intracellular lactate. To avoid apoptosis from the resultant decreased pH, these cells export lactate via monocarboxylate transporters (MCT), primarily MCT1 and MCT4, with overexpression of MCT1 and MCT4 having been linked to poor prognosis. Methods: Mouse Oral Cancer (MOC1) cells were treated with MCT-IN-1, a dual MCT1 and MCT4 inhibitor. Flow cytometry was utilized to characterize apoptosis and S-phase of the cell cycle. Bulk RNAseq data were obtained from both MCT-IN-1-treated and untreated MOC1 cells and analyzed with unbiased gene set enrichment analysis (GSEA). Leading edges of enrichment were analyzed by using the STRING database of protein-protein interactions. Results: Treatment of MOC1 cells with MCT-IN-1 resulted in decreased tumor cell count (p<0.01), increased apoptosis (p<0.01), and reduced S-phase of the cell cycle (p<0.01) compared to untreated cells. Unbiased GSEA of bulk RNAseq data, contrasting MCT-IN-1 treated versus untreated cells, revealed upregulation of endoplasmic reticulum (ER) stress (NES 1.79, FDR=0.012), suggesting possible mechanism of cell death. In addition, the glutathione conjugation gene set was found to be upregulated (NES 1.75, FDR=0.016), suggesting a possible compensatory response mechanism. Further, GSEA revealed significant enrichment of the oxidative stress and redox pathway (NES 1.74, FDR=0.016), including glutathione transferase and oxidoreductase activities. STRING analysis of upregulations in gene expression revealed a dense protein-protein interaction network, suggesting coordinated roles in detoxification (FDR = 1.00e-16) and cellular stress response mechanisms (FDR = 2.61e-41) in MOC1 cells treated with MCT-IN-1. Conclusions: We report the first characterization of the dual MCT1 and MCT4 inhibitor MCT-IN-1. Treatment of MOC1 cells in vitro with MCT-IN-1 induces tumor cell apoptosis possibly via upregulation of ER stress and further demonstrates upregulation of glutathione conjugation gene sets, suggesting a possible compensatory mechanism. Validation with in vivo studies and further evaluation of the exact mechanism of these findings are required. Citation Format: Eric V. Mastrolonardo, Víctor Díaz Barros, Zhao Lin, Hani Samarah, Julian Jackson, Adam J. Luginbuhl, Alban Linnenbach, Ubaldo Martinez-Outschoorn, Joseph M. Curry. Characterization of the dual MCT1 and MCT4 inhibitor MCT-IN-1 in MOC1 cell line demonstrates increased apoptosis and compensatory upregulation of glutathione conjugation gene sets [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6777.

Cancer ResearchVol. 85(8_Supplement_1)
Thomas Jefferson University (US), Sidney Kimmel Cancer Center (US)
Openalex Percentile: Top 90%
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.